Date	Title	View
September 22, 2023	Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
July 18, 2023	Neurogene and Neoleukin Announce Definitive Merger Agreement
March 8, 2023	Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition